Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Scope and Methodology
- Size and Growth of the Market
CHAPTER TWO: INTRODUCTION
- Miniaturization, Digitization and Informatics
- The pros and cons of POC testing
- Point of View
CHAPTER THREE: ECONOMICS, EMR AND HEALTHCARE REFORM
- Healthcare Reform
- POC and Clinical Outcomes Management
- POC' s Unmet Need
CHAPTER FOUR: TECHNOLOGY AND INDUSTRY TRENDS
- Background
- The search for non-invasive tools
- Saliva
- Breath
- Optical Techniques
- Patch Technology
- Wearable Sensors/Textiles
- The Wireless Revolution
- Lab-on-a chip
CHAPTER FIVE: VENUES FOR POC TESTING
- POC Testing in the Hospital
- POL and Clinic Testing
- Retail Outlets
- Other Professional POC Venues - Workplace Testing and Home Visits
- Home Monitoring of Individuals with Chronic Diseases
- Self-Test Sector - OTC Tests
CHAPTER SIX: MARKET ANALYSIS
- Market Overview
- Prognosis for POC growth
- Technological Challenges
- Market and Forecasts
- Self Testing/OTC
- Breakout of Non-Glucose Tests
- Professional POC Testing
- POC in world markets
- Europe
- Asia
- Rest of World
- United States
- Physician Office Labs
- United Kingdom
- HIV/AID
- Market for Rapid Flu Testin
- The Major Players
- Licenses and Distribution Agreements
CHAPTER SEVEN: POC TEST SEGMENTS
- Diabetes Testing - Blood Glucose Monitoring (BGM)
- Blood Glucose Self-Testing
- Blood Glucose Testing by Professionals
- Diabetes Testing - Glycated Hemoglobin
- Cardiovascular Diagnostics
- Cardiac Markers (AMI enzymes)
- Cholesterol/Lipid Panels
- Clinical Chemistry/Critical Care
- Hemoglobin Testing for Anemia
- Hematology
- Coagulation
- Decentralized Coagulation testing - Professional Use
- Decentralized Coagulation Testing - OTC
- Drugs of Abuse/Therapeutic Drug Monitoring
- Allergy
- Infectious Diseases
- OTC Tests for Infectious Diseases
- Professional POC Tests for Infectious Diseases
- Pharmacodiagnostics
- Sepsis
- Oncology
- Bladder Cancer
- Colon Cancer
- Prostate Cancer
- Cervical Cancer
- Women' s Health / Pregnancy/Fertility
- Emerging Tests and Technologies
- Commercial Outlook
CHAPTER EIGHT: COMPANY PROFILES MAJOR COMPANIES
- Abbott Diagnostics
- Diabetes
- Critical Care
- Hematology
- ARKRAY, Inc.
- Distribution News
- Product News
- Bayer Diabetes Care
- Beckman Coulter Inc.
- Becton, Dickinson and Company (BD)
- bioMerieux Inc.
- Bio-Rad Laboratories Inc.
- GE Healthcare
- Instrumentation Laboratory
- Inverness Medical Innovations
- Lifescan Inc.
- Nova Biomedical
- Ortho Clinical Diagnostics (OCD)
- Qiagen N.V.
- Quidel Corporation
- Radiometer A/S
- Roche Diagnostics
- Diabetes
- Cardiac Markers
- Clinical Chemistry
- Critical Care
- Siemens Healthcare Diagnostics
- Cardiac Markers
- Diabetes Care
- Blood Gases
- Urinalysis
- Sysmex Corporation
- TOSOH Corporation
- ' New Frontier' POC COMPANIES
- 3M Health Care
- 77 Elektronika Kft.
- Abaxis, Inc.
- A/C Diagnostics
- Accumetrics
- ACIST Medical Systems, Inc.
- AgaMetrix, Inc.
- Alfa Wassermann Diagnostic Technologies, LLC (AWDT)
- American Bio Medica Corp
- Audit Diagnostics
- Axis-Shield plc
- Biohit Oy
- BioIQ
- Biomerica, Inc.
- Biosite Incorporated
- B.R.A.H.M.S. AG
- Calypte Biomedical Corporation
- Chembio Diagnostic Systems, Inc.
- Chempaq A/S
- Cholestech Corporation
- Concateno plc
- DexCom, Inc.
- Diabetech, LP
- Diazyme Laboratories
- EKF-diagnostic GmbH
- ESA Biosciences Inc.
- Hain Lifescience GmbH
- HandyLab, Inc.
- Helena Laboratories USA
- Hema Diagnostic Systems (HDS)
- HemoCue AB
- HemoSense, Inc.
- Home Diagnostics, Inc.
- Horiba ABX S.A.
- Insulet Corporation
- International Technidyne Corp (ITC)
- Masimo Corporation
- Matritech
- Medical Automation Systems, Inc.
- MedMira Inc.
- Medtronic Inc.
- A. Menarini Diagnostics
- Meridian Bioscience
- MP Biomedicals LLC
- Nanosphere, Inc.
- OPTI Medical Systems, Inc.
- OraSure Technologies, Inc.
- Phadia AB
- Philips Handheld Immunoassays
- Polymedco, Inc.
- QBC Diagnostics, Inc.
- Response Biomedical Corp
- Serotec (AbD Serot
- Smiths Medical MD, Inc. (formerly Deltec, Inc.)
- Stanbio Laboratory
- Taidoc Technology Corp.
- Trinity Biotech plc
- Via Medical Corporation
- Vital Diagnostics
- Other Players
- Acrongenomics Inc.
- Alfa Scientific Designs, Inc.
- Amic AB
- Astron Clinica
- AspenBio Pharma, Inc.
- AT First Diagnostic, LLC
- bioLytical Laboratories Inc.
- Biomagnetics Diagnostics Corporation
- Bionime Corporation
- BodyTel Scientific, Inc.
- Burnet Institute
- Celerus Diagnostics
- Chelsea Technologies Group Ltd
- Claros Diagnostics
- CLX Medical, Inc.
- ContraVac, Inc.
- Decision Biomarkers Inc.
- Diabetes Sentry Products Inc.
- Diaglobal GmbH
- Diagnostic Devices, Inc.
- Diagnostics for All (DFA)
- Diagnostics for the Real World (DRW)
- Digital Bio Technology/ InCyto
- Diversa Limited (formerly Ambri Ltd.)
- DNAFORM
- DxNA
- Echo Therapeutics, Inc. (previously Sontra Medical)
- Enigma Diagnostics Limited
- Enterix Inc.
- Entra Health Systems
- Epocal, Inc.
- EUMED Biotechnology Co. Ltd.
- eScreen, Inc.
- EyeMarker Systems, Inc.
- Flexsite Diagnostics, Inc.
- Fora Care
- GenBio
- Gene Smart Wellness
- Gentag Inc.
- Glucometrics, Inc.
- Guided Therapeutics, Inc.
- Hai Kang Life Corporation
- HealthPia America
- Heidelberger-Medical-Marketing GmbH (HMM GmbH)
- Hema Metrics
- Hoana Medical, Inc.
- Idaho Technology, Inc.
- Identa Corporation
- Identigene
- Innovative Biosensors, Inc.
- Integrity Applications Ltd.
- Intel Corporation
- LifeAssays AB
- LifeSign LLC
- Lifestyle Choices Ltd
- Luminous Medical, Inc.:
- M-Biotech
- Menssana Research, Inc.
- Micromem Technologies Inc.
- Micronics Inc.
- MicroPhage, Inc.
- Multilyte Limited
- MycroLab Pty Ltd.
- Nanomix, Inc.
- National Jewish Health
- Network Biosystems
- Neuroptix Corporation
- Noninvasive Medical Technologies, Inc.
- OrSense Ltd.
- OvumOptics, Inc.
- Oxonica Diagnostics
- PlaCor, Inc.
- PointCare Technologies
- Probe Scientific Ltd
- Prometheus Laboratories Inc.
- Q-linea
- Quadraspec
- QualSec, Inc
- QuantRx Biomedical Corporation
- Quotient Diagnostics
- Rapid Pathogen Screening
- Rennesens GmbH
- Screening Devices Canada, Inc.
- Sentinel Bioactive Paper Network
- Sphere Medical Ltd.
- SIENCO
- Smiths Detection
- Solei Systems, Inc.
- Solianis Monitoring AG
- SpheroSense Technologies Inc.
- STD Test Express
- Surface Enhanced Micro Optical Fluidic Systems
- T2 Biosystems, Inc.
- TwistDx, Ltd.
- Veralight, Inc.
- Veredus Laboratories Pte
- VeriChip Corporation
- Vivacta Limited
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Table 1-1: Exchange Rate Fluctuations, 2005-2008
- Table 1-2: POC Sales by Test Category (OTC and POC), Worldwide 2008-2013
CHAPTER FOUR: TECHNOLOGY AND INDUSTRY TRENDS
- Table 4-1: Selected Non-Invasive Testing Innovations
- Table 4-2: Selected disease markers in exhaled breath
- Table 4-3: Selected POC Wireless Innovations, 2008-2009
- Table 4-4: RALS connected POC systems, 2009
- Table 4-5: Selected biochip and biosensor innovations, 2009
CHAPTER FIVE: VENUES FOR POC TESTING
- Figure 5-1: Venues for POC Testing (Hospital, Physician, Other)
- Table 5-1: POC Test Sales in the Hospital Sector (Critical Care, Glucose,
Cardiac Markers, Infectious Diseases, Coagulation, Hematology, Drugs of Abuse,
Cholesterol, Pregnancy, Urinalysis), 2008
- Table 5-2: POC Test Sales in the POL Sector (Glucose, Cholesterol, HbA1c,
Coagulation, Hematology, Chemistry/Immunoassays, Infectious Diseases, Fecal
Occult Blood, Pregnancy, Cardiac Markers, Oncology, Urinalysis, Drugs of
Abuse), 2008
- Table 5-3: Selected Small Footprint Chemistry Systems, 2009
- Table 5-4: Selected Small Footprint Hematology Systems, 2009
- Table 5-5: Selected New Small Footprint Immunoassay Systems, 2009
- Table 5-6: POC Test Sales in Other Care Venues (Glucose, Cholesterol,
Drugs of Abuse, Fecal Occult Blood, Infectious Diseases, Urinalysis,
Coagulation), 2008
- Table 5-7: Selected self-test innovations, 2008-2009
CHAPTER SIX: MARKET ANALYSIS
- Table 6-1: OTC/Self Test Sales by Test Category (Glucose, Pregnancy,
Coagulation, Fecal Occult Blood, Drugs of Abuse, HbA1c, HIV, Cholesterol,
Other) Worldwide 2008 and 2013
- Figure 6-1: Breakout of Non-Glucose Self-Testing
- Figure 6-2: Professional POC Testing Market by Test Category
- Table 6-2: Professional Point of Care Testing Market by Test Category
(Glucose, Critical Care, Cardiac Markers, Infectious Diseases,
Cholesterol/Lipids, Coagulation, Hematology, HbA1c, Chemistry/Immunoassays,
Fecal Occult Blood, Drugs of Abuse, Pregnancy, Urinalysis, Onocology, Other)
2008 and 2013
- Figure 6-3: Professional POC Testing Market by Test Category
- Table 6-3: POC Test Sales by Region (US, Europe, Asia, ROW), 2008-2013
- Table 6-4: POC Test Revenues of Selected IVD Companies, $ million,
estimated
- Table 6-5: Selected Market Expansion Deals in POC testing, 2008-2009
CHAPTER SEVEN: POC TEST SEGMENTS
- Table 7-1: World Glucose Monitoring Sales, by Company, 2005 - 2008
- Table 7-2: Selected Glucose Meter Innovations, 2008-2009
- Table 7-3: Selected Wireless Enabled Blood Glucose Monitors, 2009
- Table 7-4: Selected Continuous BGM Sales by Company, 2008
- Table 7-5: Selected Continuous Blood Glucose Systems, 2009
- Table 7-6: Glucose Meters that use GDH-PQQ technology
- Table 7-7: Selected POC HbA1c Devices, 2009
- Table 7-8: Worldwide Sales, POC CVD markers (Cholesterol -Professional,
Cholesterol OTC, AMI Enzymes), 2008-2013
- Table 7-9: Selected POC Hematology Systems, 2009
- Table 7-10: World POC Coagulation Sales(PT-Professional, PT OTC, ACT),
2008 (million)
- Table 7-11: Selected CLIA Waived PT Devices
- Table 7-12: Selected Rapid HIV Tests on the Market
- Table 7-13: Selected Rapid Infectious Disease Test Innovations
- Table 7-14: Selected Women' s Health OTC Tests
- Table 7-15: Selected POC Platform Innovations, 2008/2009
|
Related Report
|
View Cart
